Show
Sort by
-
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
-
Does gender-affirming hormonal treatment affect 30-year cardiovascular risk in transgender persons? A two-year prospective European study (ENIGI)
-
Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy : a prospective cohort study (ENIGI)
-
- Journal Article
- A1
- open access
Lower serum estradiol levels in assigned female at birth transgender people with initiation of testosterone therapy : results from the European Network for the Investigation of Gender Incongruence
-
- Journal Article
- A1
- open access
Change in grip strength in trans people and its association with lean body mass and bone density
-
Breast development in transwomen after 1 year of cross-sex hormone therapy : results of a prospective multicenter study
-
Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment
-
Bone mineral density increases in trans persons after 1 year of hormonal treatment : a multicenter prospective observational study
-
A European network for the investigation of gender incongruence : endocrine part
-
Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study